Effectiveness and safety of secukinumab in patients with moderate-to-severe plaque psoriasis – a real life retrospective study

INTRODUCTION: Clinical experience indicates that secukinumab has significant efficacy in the treatment of moderate-to-severe psoriasis and psoriatic arthritis, demonstrating a rapid onset of action, sustained response, a favourable safety profile, and an improvement of patients’ quality of life. AIM...

Descripción completa

Detalles Bibliográficos
Autores principales: Galica, Katarzyna, Lesiak, Aleksandra, Ciążyńska, Magdalena, Noweta, Marcin, Bednarski, Igor, Narbutt, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802960/
https://www.ncbi.nlm.nih.gov/pubmed/35126003
http://dx.doi.org/10.5114/ada.2020.97066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802960/
https://www.ncbi.nlm.nih.gov/pubmed/35126003
http://dx.doi.org/10.5114/ada.2020.97066

Ejemplares similares